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129 Shortened SF6 MBW is a repeatable and sensitive test in adults and
children with CF
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K. O’Neill1. 1Centre for Infection & Immunity, Queen’s University Belfast, Belfast,
United Kingdom; 2Frontier Science Ltd, Scotland, United Kingdom; 3Centre for
Health and Rehabilitation Technologies (CHART), University of Ulster, Belfast,
United Kingdom; 4Belfast Health and Social Care Trust, Belfast, United Kingdom;
5Respiratory Medicine Department, Bristol Royal Inﬁrmary, Bristol, United Kingdom
Introduction: Lung Clearance Index (LCI) derived from SF6 multiple breath washout
(MBW) is a sensitive measure of lung disease. However it can be time-consuming,
limiting its clinical use.
Aim: To compare the repeatability and sensitivity of LCI until 1/40th of starting
concentration (LCI40) to a shorter version of LCI until 1/20th of starting concentration
(LCI20).
Methods: Triplicate MBW test data from 30 stable CF patients and 30 healthy
controls were selected from a larger prospective study. MBW tests were performed
using 0.2% SF6 and a modiﬁed InnocorTM. LCI40 and LCI20 were calculated using
SimpleWashout software. Repeatability was assessed using coefﬁcient of variation
(CV%). The proportion of CF patients with abnormal results was compared. LCI normal
limits were determined from control mean+2SD. Receiver operating characteristic
(ROC) curve statistics were calculated (1.0=accurate test).
Results: CV% of LCI40 and LCI20 was comparable and not signiﬁcantly different to
controls (Table 1). The sensitivity of LCI40, LCI20 and FEV1 was 67%, 63% and 47%
respectively. Area under the ROC curve (95%CI) for LCI40, LCI20 and FEV1 were
0.87 (0.78–0.96), 0.87 (0.77–0.96) and 0.73 (0.60–0.86) respectively.
Table 1. Summary of CF and control data
CF (n = 30) Control (n = 30) p-value
Mean (SD) age 20.7 (11.1) 20.8 (10.7) 0.93
Mean (SD) LCI40 8.9 (2.4) 6.4 (0.5) <0.0001
CV% 5.2 (2.8) 4.3 (2.0) 0.20
Mean (SD) LCI20 6.6 (1.2) 5.2 (0.4) <0.0001
CV% 5.7 (3.4) 4.6 (2.3) 0.26
Conclusions: LCI20 is a repeatable and sensitive test that is shorter than LCI40, offering
a more feasible clinical measure.
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Objectives: The Innocor device contains a highly sensitive photoacoustic analyser
which allows multiple breath washout (MBW) measurements using very low
concentrations of the tracer gas SF6. Previously, use in smaller subjects has been
restricted by the need for an analyser response time <100ms to ensure accurate
estimation of lung volumes at rapid ventilation rates. Here we report the effect of
response time improvements.
Methods: A series of previously reported and novel enhancements were made to
the analyser to produce a clinically practical system with a reduced response time.
An enhanced lung model was constructed delivering highly accurate ventilation
rates and volumes. This was used to assess in vitro accuracy of volume calculation,
and the effects of ﬂow and gas signal alignment.
Results: 10−90% rise time was reduced from 154 to 88ms. In an adult/child lung
model, accuracy of volume calculation was −0.9 to 2.9% for all measurements,
including at a ventilation rate of 30/min and lung volume 0.5 L; for the un-enhanced
system, accuracy deteriorated at higher ventilation rates and smaller lung volumes.
In a separate small volume lung model (ventilation rate 60/min, lung volume 250ml,
tidal volume 100ml), mean accuracy of volume calculation for the enhanced system
was minus 0.95% (range −3.8 to 2.0%).
Conclusion: The Innocor analyser can be enhanced to reliably generate highly
accurate lung volume measurements down at volumes as low as those simulating
infant lung settings. Signal alignment is a critical factor. With these enhancements,
Innocor achieves all of the recent technical recommendations for MBW apparatus,
including those for accuracy in infant settings.
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Background: Multiple breath nitrogen washout (MBWN2) is a promising tool in
pediatric pulmonology. Data comparing recent commercially available devices are
lacking.
Objective: To compare the results obtained from 2 such devices in healthy children
and adults.
Methods: Healthy subjects were recruited to perform MBWN2 tests in duplicate
using two devices (EasyOne Pro, NDD, Switzerland − Exhalyzer D, EcoMedics,
Switzerland), in random order on the same session. Agreement between devices
was assessed by Bland-Altman plot. In a subset of adults, FRC was also measured
using helium dilution (FRC He).
Results: Acceptable values were obtained with each device in all subjects (51 adults:
21−58 y, 41 children: 5−17 y). Both devices were considered equally convenient
by children and adults. Using a given apparatus, LCI values were similar in
adults and children, which allowed to pool the data (n = 92). On average, LCI
NDD was consistently lower than LCI EM (6.54±0.57 vs 6.94±0.42, p< 0.001;
mean difference: −0.40, 95%CI: −1.59 to 0.79). EM yielded a narrower range
of normal values (p = 0.04). The intraindividual CV was lower using EM than
using NDD (2.9±2.6% vs 5.5±3.7%, p< 0.001). FRC NDD was lower than FRC
EM (2.04±0.94 L vs 2.7±1.28 L; p< 0.001). FRC He was measured in 11 adults
and corresponded to 100% (±6) of FRC EM and 81% (±7) of FRC NDD. When
compared to FRC He, underestimation of FRC by NDD was signiﬁcant (p< 0.001).
Conclusion: In normal subjects, LCI and FRC obtained using current versions of
the EasyOnePro or the EcoMedics are not interchangeable. EcoMedics yields more
reproducible LCI values, a narrower range of normal values and more accurate FRC
measurements.
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Background: In CF, lung clearance index (LCI) measured by a multiple breath ni-
trogen washout (MBWN2) is time consuming in patients with advanced respiratory
disease. Shortening the test would increase its feasibility.
Objective: To assess repeatability and diagnostic performance of LCI in CF adults,
from two acceptable runs until 1/40th (LCI2.5, conventional test), 1/25
th (LCI4) or
1/20th (LCI5) of starting N2 concentration.
Methods: Retrospective analysis of MBWN2 tests performed in duplicate in adults
with CF, using the Exhalyzer D (Ecomedics, Switzerland). Time to complete
2 measurements + between resting time (i.e. 1.5× washout time), diagnostic
performance and repeatability were assessed for LCI2.5, LCI4 and LCI5.
Results: Data from 34 CF adults were analysed (15 M, median age: 24.5 y, IQR:
21−32; mean±SD FEV1: 84.5±19.8% pr). Mean (SD) LCI2.5 was 13.73 (3.63).
Corresponding values for LCI4 and LCI5 were 9.52 (2.29) and 8.14 (1.83)
respectively. Compared to LCI2.5, repeatability of LCI4 and LCI5 were similar,
but only the former had similar diagnostic performance and a predictive value (R2)
for LCI2.5 >0.9 (R
2 = 0.92). Mean time needed to complete 2 LCI4 measurements
was 9.9min vs 15.6min for LCI2.5 (p< 0.001, time saving: 38%). Restricting the
analysis to the 6 patients with highest LCI (19.01±1.59; mean FEV1: 76% pr, range:
62−96), mean session duration decreased from 21.3 to 11.7min (time saving: 45%).
Conclusion: In this study, LCI4 appears to be a reliable and more feasible test in
CF patients with moderate to severe lung disease.
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